首页 | 本学科首页   官方微博 | 高级检索  
     


Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy
Authors:Carlos Acevedo-Gadea  Christos Hatzis  Gina Chung  Neal Fishbach  Kimberly Lezon-Geyda  Daniel Zelterman  Michael P. DiGiovanna  Lyndsay Harris  Maysa M. Abu-Khalaf
Affiliation:1. Section of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA
2. Section of Medical Oncology, Yale University School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA
3. Yale University School of Medicine, 111 Beach Rd, Fairfield, CT, 06824, USA
4. Yale Cancer Center, Yale University School of Medicine, 15 York Street, New Haven, CT, 06510-3221, USA
5. Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, New Haven, CT, 06520, USA
6. Department of Medicine, University Case Hospital, 11100 Euclid Ave, Cleveland, OH, 44106, USA
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号